These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 31586142)

  • 1. Association between genetic polymorphisms of NRF2, KEAP1, MAFF, MAFK and anti-tuberculosis drug-induced liver injury: a nested case-control study.
    Chen S; Pan H; Chen Y; Lu L; He X; Chen H; Chen R; Zhan S; Tang S
    Sci Rep; 2019 Oct; 9(1):14311. PubMed ID: 31586142
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Possible association of HMOX1 and NQO1 polymorphisms with anti-tuberculosis drug-induced liver injury: A matched case-control study.
    Yang M; Zhang H; Tao B; Pan H; Lu L; Yi H; Tang S
    J Clin Pharm Ther; 2019 Aug; 44(4):534-542. PubMed ID: 30776144
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Genetic variants in antioxidant pathway: risk factors for hepatotoxicity in tuberculosis patients.
    Nanashima K; Mawatari T; Tahara N; Higuchi N; Nakaura A; Inamine T; Kondo S; Yanagihara K; Fukushima K; Suyama N; Kohno S; Tsukamoto K
    Tuberculosis (Edinb); 2012 May; 92(3):253-9. PubMed ID: 22341855
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Association of LEPR polymorphisms with predisposition and inflammatory response in anti-tuberculosis drug-induced liver injury: A pilot prospective investigation in Western Chinese Han population.
    Zhao Z; Peng W; Zhou J; Zhou Y; Liu T; Bai H; Wu Q; Song J; Wu L; Song X; Ying B
    Infect Genet Evol; 2019 Nov; 75():103970. PubMed ID: 31325611
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The association between HLA-DQB1 polymorphism and antituberculosis drug-induced liver injury: a Case-Control Study.
    Chen R; Zhang Y; Tang S; Lv X; Wu S; Sun F; Xia Y; Zhan SY
    J Clin Pharm Ther; 2015 Feb; 40(1):110-5. PubMed ID: 25250564
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The association between BACH1 polymorphisms and anti-tuberculosis drug-induced hepatotoxicity in a Chinese cohort.
    Zhang H; Qian H; Tao B; Yang M; Gong J; Yi H; Tang S
    Infect Genet Evol; 2018 Dec; 66():217-221. PubMed ID: 30316884
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The A/A Genotype of XPO1 rs4430924 Is Associated With Higher Risk of Antituberculosis Drug-Induced Hepatotoxicity in Chinese Patients.
    He X; Zhang H; Tao B; Yang M; Chen H; Lu L; Yi H; Pan H; Tang S
    J Clin Pharmacol; 2019 Jul; 59(7):1014-1021. PubMed ID: 30817003
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lack of association between genetic polymorphisms of CYP3A4, CYP2C9 and CYP2C19 and antituberculosis drug-induced liver injury in a community-based Chinese population.
    Tang SW; Lv XZ; Chen R; Wu SS; Yang ZR; Chen DF; Zhan SY
    Clin Exp Pharmacol Physiol; 2013 May; 40(5):326-32. PubMed ID: 23469989
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Is anti-tuberculosis drug-induced hepatotoxicity due to a change in pharmacokinetics caused by alterations in antioxidant gene expression and polymorphisms in the
    Ji G; Huang W; He J
    Int J Clin Pharmacol Ther; 2020 Feb; 58(2):67-73. PubMed ID: 31670652
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Genetic Polymorphisms in Antioxidant Enzymes Modulate the Susceptibility of Idiosyncratic Antituberculous Drug-Induced Liver Injury and Treatment Outcomes in Patients with Tuberculosis.
    Sun Q; Sha W; Liu HP; Wang P; Liu ZB; Sun WW; Xiao HP
    Pharmacotherapy; 2020 Jan; 40(1):4-16. PubMed ID: 31742742
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Association of ABO blood group and antituberculosis drug-induced liver injury: A case-control study from a Chinese Han population.
    Tao B; Yang M; Chen H; Pan H; Liu W; Yi H; Tang S
    J Clin Pharm Ther; 2020 Aug; 45(4):638-645. PubMed ID: 32259340
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Small MAF genes variants and chronic myeloid leukemia.
    Martínez-Hernández A; Gutierrez-Malacatt H; Carrillo-Sánchez K; Saldaña-Alvarez Y; Rojas-Ochoa A; Crespo-Solis E; Aguayo-González A; Rosas-López A; Ayala-Sanchez JM; Aquino-Ortega X; Orozco L; Cordova EJ
    Eur J Haematol; 2014 Jan; 92(1):35-41. PubMed ID: 24118457
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Association of UGT2B7 polymorphisms with risk of induced liver injury by anti-tuberculosis drugs in Chinese Han.
    Chen G; Wu SQ; Feng M; Wang Y; Wu JC; Ji GY; Zhang MM; Liu QQ; He JQ
    Int J Immunopathol Pharmacol; 2017 Dec; 30(4):434-438. PubMed ID: 28934901
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Transforming growth factor-beta 1 polymorphisms and anti-tuberculosis drug-induced liver injury. Polymorphisms in TGFβ1 and its relationship with anti-tuberculosis drug-induced liver injury.
    Wu S; Wang Y; Zhang M; Wang M; He JQ
    Therapie; 2019 Jun; 74(3):399-406. PubMed ID: 30093157
    [TBL] [Abstract][Full Text] [Related]  

  • 15. CYP7A1, BAAT and UGT1A1 polymorphisms and susceptibility to anti-tuberculosis drug-induced hepatotoxicity.
    Chen R; Wang J; Tang SW; Zhang Y; Lv XZ; Wu SS; Yang ZR; Xia YY; Chen DF; Zhan SY
    Int J Tuberc Lung Dis; 2016 Jun; 20(6):812-8. PubMed ID: 27155186
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Association between NR1I2 polymorphisms and susceptibility to anti-tuberculosis drug-induced hepatotoxicity in an Eastern Chinese Han population: A case-control study.
    Yang M; Pan H; Chen H; Liu W; Lu L; He X; Yi H; Tang S
    Infect Genet Evol; 2020 Sep; 83():104349. PubMed ID: 32387752
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The role of the genetic variant FECH rs11660001 in the occurrence of anti-tuberculosis drug-induced liver injury.
    Zhang M; Zhu J; Wang N; Liu W; Lu L; Pan H; He X; Yi H; Tang S
    J Clin Pharm Ther; 2022 Aug; 47(8):1276-1283. PubMed ID: 35470464
    [TBL] [Abstract][Full Text] [Related]  

  • 18. NAT2 polymorphisms and susceptibility to anti-tuberculosis drug-induced liver injury: a meta-analysis.
    Wang PY; Xie SY; Hao Q; Zhang C; Jiang BF
    Int J Tuberc Lung Dis; 2012 May; 16(5):589-95. PubMed ID: 22409928
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Incidence, clinical features and impact on anti-tuberculosis treatment of anti-tuberculosis drug induced liver injury (ATLI) in China.
    Shang P; Xia Y; Liu F; Wang X; Yuan Y; Hu D; Tu D; Chen Y; Deng P; Cheng S; Zhou L; Ma Y; Zhu L; Gao W; Wang H; Chen D; Yang L; He P; Wu S; Tang S; Lv X; Shu Z; Zhang Y; Yang Z; Chen Y; Li N; Sun F; Li X; He Y; Garner P; Zhan S
    PLoS One; 2011; 6(7):e21836. PubMed ID: 21750735
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Genetic polymorphisms in PXR and NF-κB1 influence susceptibility to anti-tuberculosis drug-induced liver injury.
    Zhang J; Zhao Z; Bai H; Wang M; Jiao L; Peng W; Wu T; Liu T; Chen H; Song X; Wu L; Hu X; Wu Q; Zhou J; Song J; Lyv M; Ying B
    PLoS One; 2019; 14(9):e0222033. PubMed ID: 31490979
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.